<code id='50D76996FA'></code><style id='50D76996FA'></style>

<acronym id='50D76996FA'></acronym>

<center id='50D76996FA'><center id='50D76996FA'><tfoot id='50D76996FA'></tfoot></center><abbr id='50D76996FA'><dir id='50D76996FA'><tfoot id='50D76996FA'></tfoot><noframes id='50D76996FA'>

<optgroup id='50D76996FA'><strike id='50D76996FA'><sup id='50D76996FA'></sup></strike><code id='50D76996FA'></code></optgroup>

<b id='50D76996FA'><label id='50D76996FA'><select id='50D76996FA'><dt id='50D76996FA'><span id='50D76996FA'></span></dt></select></label></b><u id='50D76996FA'></u>

~~<i id='50D76996FA'><strike id='50D76996FA'><tt id='50D76996FA'><pre id='50D76996FA'></pre></tt></strike></i>~~

Home» Wikipedia» entertainment

entertainment

entertainment

author：leisure time 2025-09-28 16:58:05 Page View：29296

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

advertisement

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Micronoma's microbiome cancer diagnostic approach under fire
Next article： Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

focus

How to save PrEP access — and even expand it

How to save PrEP access — and even expand it

UndertheAffordableCareAct,healthinsurersarerequiredtocoverallcostsassociatedwithpreventivecare—inclu

Weighted lottery helped low

Weighted lottery helped low

AmedicalassistantataUniversityofWashingtonMedicineclinicpreparesatwo-shotdoseofEvusheldinJanuary2022

BioMarin wins approval for gene therapy to treat hemophilia A

BioMarin wins approval for gene therapy to treat hemophilia A

AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

Covid hospitalizations on the rise, Humana says

MoreolderadultshavebeenhospitalizedforCovid-19overthepastseveralweeks,accordingtodatareviewedbyhealt

read more